SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will participate on a panel titled "Life Sciences Incubation Models" at the International Association of Research Parks World Conference in Raleigh, NC
News | 06. 04. 2009
